Shinji Kamisuki Selected Research

Shinji Kamisuki Research Topics

Disease

13	Neoplasms (Cancer) 01/2022 - 11/2003
7	Infections 01/2019 - 11/2013
2	Stomach Neoplasms (Stomach Cancer) 02/2002 - 02/2002
1	Prostatic Neoplasms (Prostate Cancer) 08/2023
1	Dysbiosis 01/2023
1	Weight Loss (Weight Reduction) 01/2023
1	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 01/2023
1	Enzootic Bovine Leukosis (Bovine Leukosis) 01/2023
1	Inflammation (Inflammations) 01/2023
1	Meningioma (Meningiomas) 01/2022
1	Human Influenza (Influenza) 07/2019
1	Carcinoma (Carcinomatosis) 03/2019
1	Neurodegenerative Diseases (Neurodegenerative Disease) 04/2016
1	Stroke (Strokes) 04/2016
1	Wounds and Injuries (Trauma) 04/2016
1	Nervous System Diseases (Neurological Disorders) 04/2016
1	Hepatitis B 12/2015
1	Reinfection 12/2015
1	Hypoxia (Hypoxemia) 01/2015
1	Hepatocellular Carcinoma (Hepatoma) 01/2015
1	Anaphylaxis (Anaphylactic Shock) 08/2014
1	Edema (Dropsy) 08/2014
1	Hepatitis A (Hepatitis, Infectious) 12/2013
1	Breast Neoplasms (Breast Cancer) 01/2013
1	Fanconi Anemia (Fanconi's Anemia) 11/2012
1	Body Weight (Weight, Body) 08/2009

Drug/Important Bio-Agent (IBA)

3	dehydroaltenusinIBA 01/2007 - 02/2002
2	Antiviral Agents (Antivirals)IBA 01/2023 - 12/2015
2	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2022 - 09/2014
2	MA026IBA 05/2017 - 12/2013
2	Tamoxifen FDA LinkGeneric 09/2015 - 01/2013
2	Proteins (Proteins, Gene)FDA Link 01/2015 - 11/2012
2	DNA (Deoxyribonucleic Acid)IBA 11/2012 - 12/2011
1	CytokinesIBA 08/2023
1	pelargonidinIBA 08/2023
1	Flutamide (Eulexin)FDA LinkGeneric 08/2023
1	AcidsIBA 01/2023
1	3-Hydroxybutyric Acid (beta-Hydroxybutyric Acid)IBA 01/2023
1	Biopolymers (Biopolymer)IBA 01/2023
1	Dextran SulfateIBA 01/2023
1	avenaciolideIBA 01/2022
1	Histone Deacetylases (Histone Deacetylase)IBA 01/2021
1	Radiation-Sensitizing AgentsIBA 01/2021
1	pyrenocine AIBA 12/2019
1	NucleosidesIBA 07/2019
1	sulfoquinovosylacylpropanediolIBA 03/2019
1	Chloramphenicol (Chloromycetin)FDA Link 01/2019
1	Phosphoric Monoester Hydrolases (Phosphatases)IBA 01/2019
1	LipidsIBA 12/2018
1	Claudin-1IBA 05/2017
1	Polysaccharides (Glycans)IBA 01/2017
1	Glutamic Acid (Glutamate)FDA Link 04/2016
1	PolyketidesIBA 12/2015
1	sodium-bile acid cotransporterIBA 12/2015
1	vanitaracin AIBA 12/2015
1	ridaifen GIBA 09/2015
1	Protein Glutamine gamma Glutamyltransferase 2IBA 01/2015
1	karuquinone AIBA 09/2014
1	karuquinone BIBA 09/2014
1	4-hydroxyphenylethanolIBA 08/2014
1	Anti-Allergic Agents (Antiallergic Agents)IBA 08/2014
1	Immunoglobulin E (IgE)IBA 08/2014
1	sulochrinIBA 11/2013
1	ridaifen-BIBA 01/2013
1	Estrogen ReceptorsIBA 01/2013
1	Cisplatin (Platino)FDA LinkGeneric 11/2012
1	CamptothecinIBA 12/2011
1	Type I DNA Topoisomerases (Topoisomerase I)IBA 12/2011
1	2- cyclohexylidenhydrazo- 4- phenyl- thiazoleIBA 12/2011
1	Blood Glucose (Blood Sugar)IBA 08/2009
1	fatostatinIBA 08/2009
1	DNA Polymerase I (Klenow Fragment)IBA 01/2007
1	Cytotoxins (Cytolysins)IBA 07/2004
1	pseudodeflectusinIBA 07/2004
1	petasiphenolIBA 11/2003
1	CurcuminIBA 11/2003
1	Antineoplastic Agents (Antineoplastics)IBA 02/2002
1	ThymidineIBA 02/2002

Therapy/Procedure

1	Therapeutics 01/2022
1	Radiotherapy 01/2021
1	Intravenous Injections 03/2019
1	Intravenous Administration 03/2019